nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens
|
Banerjee, Dithi |
|
|
156 |
C |
p. |
artikel |
2 |
Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays
|
Zhuo, Ran |
|
|
156 |
C |
p. |
artikel |
3 |
Corrigendum to ‘Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong’[Journal of Clinical Virology 148 (2022) 105081]
|
Tsang, Alan K.L. |
|
|
156 |
C |
p. |
artikel |
4 |
Editorial Board
|
|
|
|
156 |
C |
p. |
artikel |
5 |
ESCV/PASCV Membership
|
|
|
|
156 |
C |
p. |
artikel |
6 |
Genomic characterization of coxsackievirus A22 from a regional university hospital in the Netherlands
|
Cassidy, Hayley |
|
|
156 |
C |
p. |
artikel |
7 |
Impact of rhinovirus on hospitalization during the COVID-19 pandemic: A prospective cohort study.
|
Scotta, Marcelo Comerlato |
|
|
156 |
C |
p. |
artikel |
8 |
Importance of internal controls to monitor adequate specimen collection: The case of orthopoxvirus real-time PCR
|
Mostafa, Heba H. |
|
|
156 |
C |
p. |
artikel |
9 |
Multicenter performance evaluation of the Elecsys HCV Duo immunoassay
|
Majchrzak, Mario |
|
|
156 |
C |
p. |
artikel |
10 |
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection
|
Cheng, Samuel SM |
|
|
156 |
C |
p. |
artikel |